Covered recipient · General Payments record
DIANA ALUYEN
Allopathic & Osteopathic Physicians Hospitalist
General Payments · PY2018–2020
$1,789.23
- Reported across 32 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2020 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $183.04 | 12 |
By paying entity
PY2020 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $87.95 | 6 |
| Lilly USA, LLC | $24.30 | 2 |
| SANOFI-AVENTIS U.S. LLC | $21.37 | 1 |
| IBSA Pharma Inc. | $19.13 | 1 |
| Amarin Pharma Inc. | $15.84 | 1 |
| Acerta Pharma LLC | $14.45 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2020 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amarin Pharma Inc. | $15.84 | 01/16/2020 | Food and Beverage | Undisputed | 01/23/2026 | 739922887 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.45 | 02/17/2020 | Food and Beverage | Undisputed | 01/23/2026 | 736137669 | CMS |
| IBSA Pharma Inc. | $19.13 | 02/25/2020 | Food and Beverage | Undisputed | 01/23/2026 | 719679131 | CMS |
| Lilly USA, LLC | $12.57 | 01/23/2020 | Food and Beverage | Undisputed | 01/23/2026 | 728434123 | CMS |
| Lilly USA, LLC | $11.73 | 02/20/2020 | Food and Beverage | Undisputed | 01/23/2026 | 728430779 | CMS |
| Novo Nordisk Inc | $12.47 | 01/07/2020 | Food and Beverage | Undisputed | 01/23/2026 | 744568263 | CMS |
| Novo Nordisk Inc | $15.39 | 01/09/2020 | Food and Beverage | Undisputed | 01/23/2026 | 744560609 | CMS |
| Novo Nordisk Inc | $15.18 | 02/06/2020 | Food and Beverage | Undisputed | 01/23/2026 | 744601085 | CMS |
| Novo Nordisk Inc | $14.71 | 02/14/2020 | Food and Beverage | Undisputed | 01/23/2026 | 744597671 | CMS |
| Novo Nordisk Inc | $14.54 | 02/19/2020 | Food and Beverage | Undisputed | 01/23/2026 | 744729103 | CMS |
| Novo Nordisk Inc | $15.66 | 03/10/2020 | Food and Beverage | Undisputed | 01/23/2026 | 744638387 | CMS |
| SANOFI-AVENTIS U.S. LLC | $21.37 | 01/14/2020 | Food and Beverage | Undisputed | 01/23/2026 | 744132303 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020
- Generated from
- OP_DTL_GNRL_PGYR2020_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.